Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Koomesh
  4. Articles

  5. Expression and characterization of recombinant human epidermal growth factor receptor antigene (HER-2) as an indicator of breast cancer in yeast fermented systems
  6. Scopus by Title (Ref)

Koomesh

Journal of Semnan University of Medical Sciences

Home
Current IssueArchiveIn PressAccepted ManuscriptsSearch
Instructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Publication Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Optimization of HER2-based and cell-based ELISA for detection of trastuzumab biosimilar

- Ahmadzadeh M. , et al.

2. Construction of recombinant Pichia pastoris expressing single-chain antibody fragment against extracellular domain of EpCAM

- Mohammadgholizad F. , et al.

3. Construction of recombinant yeast expressing EpEX as a suitable candidate in cancer diagnosis and therapy

- Zamani M. , et al.

4. Production of human single-chain fragment antibody (ScFv) against human epidermal growth factor receptor-2 (HER-2) by phage display technology

- Foroumadi S. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • Archive
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Publication Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.